GLP-1 Receptor Agonists in Epilepsy: Separating Evidence for Antiseizure Activity, Neuroprotection, and Disease Modification

Yuliy A. Gorgul, Aleksey V. Zaitsev

Open source

DOI
10.3390/ijms27188036
Published
2026-09-09
Container
International Journal of Molecular Sciences
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms27188036,
  title = {GLP-1 Receptor Agonists in Epilepsy: Separating Evidence for Antiseizure Activity, Neuroprotection, and Disease Modification},
  author = {Yuliy A. Gorgul and Aleksey V. Zaitsev},
  year = {2026},
  journal = {International Journal of Molecular Sciences},
  doi = {10.3390/ijms27188036},
  url = {https://doi.org/10.3390/ijms27188036}
}

RIS

TY  - JOUR
TI  - GLP-1 Receptor Agonists in Epilepsy: Separating Evidence for Antiseizure Activity, Neuroprotection, and Disease Modification
AU  - Yuliy A. Gorgul
AU  - Aleksey V. Zaitsev
PY  - 2026
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27188036
UR  - https://doi.org/10.3390/ijms27188036
ER  - 

APA

Gorgul, Y. A., & Zaitsev, A. V. (2026). GLP-1 Receptor Agonists in Epilepsy: Separating Evidence for Antiseizure Activity, Neuroprotection, and Disease Modification. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188036

Source records